Kang YA, Choi HR, Na JI, Huh CH, Kim MJ, Youn SW, Kim KH, Park KC
Chinas growing middle-class urban population represents an estimated 120 million commercially addressable obesity treatment patients
For context, semaglutide and tirzepatide do not produce dysesthesia at clinically significant rates, though a recent paper in PMC examined allodynia and dysesthesia reports across GLP-1 medications more broadly
DOI: 10.1096/fj.05-3786fje
Semaglutide injections, whether used for managing type 2 diabetes (under the brand name Ozempic) or for weight loss (marketed as Wegovy), can be quite costly, particularly for those without insurance
GLP-1 Medication GLP-1 medications help regulate appetite and fullness by mimicking a natural hormone your body already uses to signal satiety